Neuroscience
Latrepirdine not effective in Huntington's disease
(HealthDay)—Although safe and well tolerated, the experimental small molecule latrepirdine does not improve cognition after six months of treatment in patients with mild-to-moderate Huntington's disease (HD), according ...
Nov 1, 2012
0
0